Figure 1 Diagnostic flowchart for patients with suspected heart failure—showing alternative ‘echocardiography first’ (blue) or ‘natriuretic peptide first’

Slides:



Advertisements
Similar presentations
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the.
Advertisements

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 by, John J.V. McMurray, Stamatis Adamopoulos, Stefan D. Anker, Angelo.
B-type natriuretic peptide in paediatric patients with congenital heart disease by Andreas Koch, Stefan Zink, and Helmut Singer EHJ Volume 27(7):
Current Management of Heart Failure GP clinical update 17 th June 2015 Dr Raj Bilku Consultant Cardiologist Clinical Lead Cardiology QEH.
To know more visit HeartFailure.com © 2015 Novartis Pharma AG, May 2015, GLCM/HTF/0028 HEART FAILURE DISEASE MANAGEMENT STANDARDS.
Heart Failure: a community-based diagnostic clinic & service
Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment.
Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians by Willem J. Remme, John.
To know more visit HeartFailure.com © 2015 Novartis Pharma AG, May 2015, GLCM/HTF/0028 HEART FAILURE PATIENT QUALITY OF LIFE STATISTICS.
Acute viral myocarditis by Robert Dennert, Harry J. Crijns, and Stephane Heymans EHJ Volume 29(17): August 25, 2008 Published on behalf of the.
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 by , Kenneth Dickstein, Alain Cohen-Solal, Gerasimos Filippatos,
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Management of Pulmonary Embolism: An Update J Am.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010.
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for the management of patients.
Imaging and atrial fibrillation: the role of multimodality imaging in patient evaluation and management of atrial fibrillation by Laurens F. Tops, Martin.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate.
To know more visit HeartFailure.com © 2016 Novartis Pharma AG, July 2016, GLCM/HTF/0028c HEART FAILURE DISEASE MANAGEMENT STANDARDS.
Arginase I enhances vascular smooth muscle cell proliferation by increasing intracellular polyamine production (A and B) Arginase I enhances cell proliferation.
Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.
Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.
Figure 1 Alcohol consumption. A
Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,
Figure 1 Initial management of a patient with acute heart failure
Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;
<sup>d</sup>Stands for as long as it is well tolerated.
Figure 1 Flow diagram displaying the proportions of patients with troponin measurements available from all eligible patients and the resulting study population.
Figure 1 Patient flow chart.
Figure 1 Representative longitudinal strain analysis in an apical two-chamber view. The view is presented in the left panel and the longitudinal strain.
Figure 2 The incidence of new onset AF, strokes, heart failure, and mortality according to the BMI (/ person-years). (Left: BMI
Figure 1 The flowchart depicts the total number of procedures in the Western Denmark Heart Registry (WDHR) and the exclusion of patients; NPR, National.
Figure 1 Prevalence of functional mitral regurgitation according to NYHA functional class (A; P 
Figure 1. Nonadherence to guidelines for prescribing antiplatelet and anticoagulant therapy in 144 patients with atrial fibrillation who attend a Spanish.
Figure 1 Flow chart of study selection.
Figure 1. Suggested algorithm for locoregional lymph node staging in patients with non-metastatic NSCLC. CT, computed tomography; EBUS, endoscopic bronchial.
Figure 1 Pulmonary vein anatomical locations
Figure 1 Incidence and total numbers of SCD in patients with depressed LV systolic function and in patients with preserved LV function. The incidence of.
Figure 1 Study flow chart
Figure 3. Proposed algorithm of treatment for patients with a diagnosis of PI [prepouch ileitis]. From: Prepouch Ileitis After Ileal Pouch-anal Anastomosis:
Treatment of Heart Failure With Preserved Ejection Fraction: Have We Been Pursuing the Wrong Paradigm?  Gerard O. Oghlakian, MD, Ilke Sipahi, MD, James.
Diabetes Mellitus and Heart Failure
Clyde W. Yancy et al. JACC 2017;70:
Figure 7 European Society of Cardiology 2016
G. Michael Felker et al. JCHF 2014;2:
Date of download: 2/22/2017 © The European Society of Cardiology All rights reserved. For permissions please
Time frames for the application of noninvasive positive-pressure ventilation in acute respiratory failure (ARF) according to the severity and end-of-life.
Figure 1 Rates of complications and mortality during index admission for atrial fibrillation ablation for the overall ... Figure 1 Rates of complications.
Treatment of Heart Failure With Preserved Ejection Fraction: Have We Been Pursuing the Wrong Paradigm?  Gerard O. Oghlakian, MD, Ilke Sipahi, MD, James.
Figure 1 Unadjusted Kaplan–Meier curves for all-cause mortality in the transcatheter mitral valve repair and ... Figure 1 Unadjusted Kaplan–Meier curves.
Figure 1 Mechanism of mortality benefit associated with radial access
Treatment algorithm for managing chronic thromboembolic pulmonary hypertension (CTEPH), from the European Society of Cardiology/European Respiratory Society.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Editorial Heart Failure Clinics
Take home figure The protective role of CNP/NPR-B/NPRC.
The Research Question Heart failure (HF) and atrial fibrillation (AF) frequently coexist and are associated with many adverse outcomes HF and AF share.
Figure 1 Selection algorithm of patients being included in the German Aortic Valve Registry in 2014 and Figure 1 Selection algorithm of patients.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1 Immunohistochemistry for human cell differentiation molecules in samples of the right ventricular septum from ... Figure 1 Immunohistochemistry.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1 Patient selection.
Figure 1 Grant agencies and charitable foundations supporting Plan S.
Pharmacological management of patients with newly discovered atrial fibrillation. Pharmacological management of patients with newly discovered atrial fibrillation.
Pharmacological management of patients with recurrent paroxysmal atrial fibrillation. Pharmacological management of patients with recurrent paroxysmal.
Pharmacological management of patients with recurrent persistent or permanent atrial fibrillation. Pharmacological management of patients with recurrent.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Distribution of systolic pulmonary artery pressure (Ppa) in relation to functional class (FC) for congenital heart disease patients with a) atrial septal.
European Society of Cardiology guidelines for the diagnosis of a) clinically suspected high-risk pulmonary embolism (PE) and b) clinically suspected non-high-risk.
Treatment algorithm for chronic thromboembolic pulmonary hypertension.
Presentation transcript:

Figure 1 Diagnostic flowchart for patients with suspected heart failure—showing alternative ‘echocardiography first’ (blue) or ‘natriuretic peptide first’ (red) approaches. From: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J. 2012;33(14):1787-1847. doi:10.1093/eurheartj/ehs104 Eur Heart J | © The European Society of Cardiology 2012. All rights reserved. For permissions please email: journals.permissions@oup.com

Figure 2 Treatment options for patients with chronic symptomatic systolic heart failure (NYHA functional class II–IV). From: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J. 2012;33(14):1787-1847. doi:10.1093/eurheartj/ehs104 Eur Heart J | © The European Society of Cardiology 2012. All rights reserved. For permissions please email: journals.permissions@oup.com

Figure 3 Recommendations for controlling the ventricular rate in patients with heart failure and persistent/permanent atrial fibrillation and no evidence of acute decompensation*. From: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J. 2012;33(14):1787-1847. doi:10.1093/eurheartj/ehs104 Eur Heart J | © The European Society of Cardiology 2012. All rights reserved. For permissions please email: journals.permissions@oup.com

Figure 4 Initial assessment of patient with suspected acute heart failure. ECG = electrocardiogram; ETT = endotracheal tube; IABP = intra-aortic balloon pump; NIV = non-invasive ventilation; NP = natriuretic peptide. From: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J. 2012;33(14):1787-1847. doi:10.1093/eurheartj/ehs104 Eur Heart J | © The European Society of Cardiology 2012. All rights reserved. For permissions please email: journals.permissions@oup.com

Figure 5 Algorithm for management of acute pulmonary oedema/congestion. From: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J. 2012;33(14):1787-1847. doi:10.1093/eurheartj/ehs104 Eur Heart J | © The European Society of Cardiology 2012. All rights reserved. For permissions please email: journals.permissions@oup.com

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.